[{"Assets_0_Q3_USD":108047000.0,"CommonStockSharesOutstanding_0_Q3_shares":32608485.0,"NetIncomeLoss_1_Q3_USD":-12444000.0,"NetIncomeLoss_3_Q3_USD":-43948000.0,"StockholdersEquity_0_Q3_USD":99074000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":32591550.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":30729752.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":32591550.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":30729752.0,"Ticker":"CARA","CIK":"1346830","name":"CARA THERAPEUTICS, INC.","OfficialName":"Cara Therapeutics Inc. Common Stock","form":"10-Q","period":"20170930","fy":"2017.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"703167627.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20171102"}]